Maureen E. Hoatlin - Publications

Publications (8)

XB-PERS-834

Publications By Maureen E. Hoatlin

???pagination.result.count???

???pagination.result.page??? 1

Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors., Landais I, Hiddingh S, McCarroll M, Yang C, Sun A, Turker MS, Snyder JP, Hoatlin ME., Mol Cancer. December 31, 2009; 8 133.
The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways., Sobeck A, Stone S, Landais I, de Graaf B, Hoatlin ME., J Biol Chem. September 18, 2009; 284 (38): 25560-8.
A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway., Landais I, Sobeck A, Stone S, Lachapelle A, Hoatlin ME., Int J Cancer. February 15, 2009; 124 (4): 783-92.
Fanconi anemia proteins stabilize replication forks., Wang LC, Stone S, Hoatlin ME, Gautier J., DNA Repair (Amst). December 1, 2008; 7 (12): 1973-81.
Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9., Stone S, Sobeck A, van Kogelenberg M, de Graaf B, Joenje H, Christian J, Hoatlin ME., Genes Cells. July 1, 2007; 12 (7): 841-51.
DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2., Sobeck A, Stone S, Hoatlin ME., Mol Cell Biol. June 1, 2007; 27 (12): 4283-92.
Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks., Sobeck A, Stone S, Costanzo V, de Graaf B, Reuter T, de Winter J, Wallisch M, Akkari Y, Olson S, Wang W, Joenje H, Christian JL, Lupardus PJ, Cimprich KA, Gautier J, Hoatlin ME., Mol Cell Biol. January 1, 2006; 26 (2): 425-37.
The Fanconi anemia gene product FANCF is a flexible adaptor protein., Léveillé F, Blom E, Medhurst AL, Bier P, Laghmani el H, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, Patel KJ, Hoatlin ME, Joenje H, de Winter JP., J Biol Chem. September 17, 2004; 279 (38): 39421-30.

Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors., Landais I, Hiddingh S, McCarroll M, Yang C, Sun A, Turker MS, Snyder JP, Hoatlin ME., Mol Cancer. December 31, 2009; 8 133.

The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways., Sobeck A, Stone S, Landais I, de Graaf B, Hoatlin ME., J Biol Chem. September 18, 2009; 284 (38): 25560-8.

A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway., Landais I, Sobeck A, Stone S, Lachapelle A, Hoatlin ME., Int J Cancer. February 15, 2009; 124 (4): 783-92.

Fanconi anemia proteins stabilize replication forks., Wang LC, Stone S, Hoatlin ME, Gautier J., DNA Repair (Amst). December 1, 2008; 7 (12): 1973-81.

Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9., Stone S, Sobeck A, van Kogelenberg M, de Graaf B, Joenje H, Christian J, Hoatlin ME., Genes Cells. July 1, 2007; 12 (7): 841-51.

DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2., Sobeck A, Stone S, Hoatlin ME., Mol Cell Biol. June 1, 2007; 27 (12): 4283-92.

Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks., Sobeck A, Stone S, Costanzo V, de Graaf B, Reuter T, de Winter J, Wallisch M, Akkari Y, Olson S, Wang W, Joenje H, Christian JL, Lupardus PJ, Cimprich KA, Gautier J, Hoatlin ME., Mol Cell Biol. January 1, 2006; 26 (2): 425-37.

The Fanconi anemia gene product FANCF is a flexible adaptor protein., Léveillé F, Blom E, Medhurst AL, Bier P, Laghmani el H, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, Patel KJ, Hoatlin ME, Joenje H, de Winter JP., J Biol Chem. September 17, 2004; 279 (38): 39421-30.

???pagination.result.page??? 1